Literature DB >> 6818035

Metabolic clearance rate of immunoreactive vasopressin in man.

M Benmansour, M Rainfray, F Paillard, R Ardaillou.   

Abstract

Metabolic clearance of synthetic arginine vasopressin (AVP) has been measured in sixteen healthy subjects and ten uraemic patients on maintenance haemodialysis. Plasma AVP was measured using a specific radioimmunoassay at different intervals after a single injection of 2 micrograms AVP. The theoretical curve which fitted best with the disappearance curve was the sum of two exponentials in twenty-two subjects and of three exponentials in the other four. Metabolic clearance rate and the volume of fast initial distribution were 287.1 ml min-1 (m2)-1 and 219.3 ml/kg b.w., respectively, in normal subjects. Metabolic clearance rate was considerably lower in the uraemic group. This emphasizes the role of kidneys in the degradation of AVP and may account, at least in part, for the higher basal plasma value of this hormone observed in uraemic patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818035     DOI: 10.1111/j.1365-2362.1982.tb02228.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1984-07

2.  Vasopressin and the pathogenesis of chronic renal failure.

Authors:  D P Brooks; H A Solleveld; L C Contino
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

3.  Validation of an integrative mathematical model of dehydration and rehydration in virtual humans.

Authors:  W Andrew Pruett; John S Clemmer; Robert L Hester
Journal:  Physiol Rep       Date:  2016-11

4.  Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.

Authors:  Debbie Zittema; Niek F Casteleijn; Stephan J L Bakker; Lianne S M Boesten; A A Margreeth Duit; Casper F M Franssen; Carlo A J M Gaillard; Ron T Gansevoort
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 5.  Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers.

Authors:  G Leng; N Sabatier
Journal:  J Neuroendocrinol       Date:  2016-10       Impact factor: 3.627

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.